StockData
Beam Therapeutics Inc. logo

Beam Therapeutics Inc. (BEAM) KPIs and segments

BEAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/304% below fair value
$22.83−1.20 (-4.99%)

Close on Nov 13, 2026Market cap $2.36BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Beam Therapeutics's business

Coming soon

This tab will track the numbers specific to Beam Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?